Peptide data sheet
BRP
GLP-1 · BRINP2-related peptide
Verdict
promisingno human data yet
Quick answer
BRP is a 12-amino-acid peptide Stanford identified in 2025 using an AI model that scanned thousands of prohormone fragments. In mice and pigs it was commonly researched for appetite, with reported reductions in food intake and, notably, no observed nausea. There are no human trials, it is not approved, and it is not available for human use — so the honest verdict is Promising but unproven.
- Class
- Non-incretin appetite-signaling peptide (research-grade)
- Half-life
- Not established in humans
- FDA status
- Not FDA-approved (investigational research peptide; not available for human use)
Which form actually works?
Injectable (subcutaneous, research)
Promising
The route used in the published animal studies. Reported effects on food intake in mice and pigs are the entire evidence base; no human study has tested this form.
Any human-use product
Unproven
No BRP product has been tested in a human trial or authorized for human use. Anything sold for human consumption is outside what the research supports.